HCAT

Health Catalyst Inc

HCAT, USA

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

https://www.healthcatalyst.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
HCAT
stock
HCAT

CareCloud (NASDAQ:CCLD) & Health Catalyst (NASDAQ:HCAT) Financial Comparison Defense World

Read more →
HCAT
stock
HCAT

Director’s Major Stock Sale Shakes Up Health Catalyst! TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$3.9444

Analyst Picks

Strong Buy

7

Buy

2

Hold

4

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.55

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-6.70 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-3.79 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-6.91 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Low

0.77

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 91.90% of the total shares of Health Catalyst Inc

1.

First Light Asset Management, LLC

(17.3789%)

since

2025/06/30

2.

BlackRock Inc

(8.0308%)

since

2025/06/30

3.

Vanguard Group Inc

(5.9349%)

since

2025/06/30

4.

Whetstone Capital Advisors, LLC

(5.3022%)

since

2025/06/30

5.

Impax Asset Management Group PLC

(3.9077%)

since

2025/06/30

6.

Impax Small Cap Institutional

(3.9077%)

since

2025/07/31

7.

Impax US Small Cap Strategy Composite

(3.9077%)

since

2025/07/31

8.

Vanguard Total Stock Mkt Idx Inv

(2.9339%)

since

2025/07/31

9.

PRIMECAP Management Company

(2.8231%)

since

2025/06/30

10.

Dimensional Fund Advisors, Inc.

(2.8177%)

since

2025/06/30

11.

Portolan Capital Management, LLC

(2.8141%)

since

2025/06/30

12.

Nepsis, Inc.

(2.4513%)

since

2025/06/30

13.

PRIMECAP Odyssey Aggressive Growth

(2.396%)

since

2025/06/30

14.

Geode Capital Management, LLC

(2.3623%)

since

2025/06/30

15.

iShares Russell 2000 ETF

(2.33%)

since

2025/08/31

16.

State Street Corp

(1.7434%)

since

2025/06/30

17.

Strategic Advisers U.S. Total Stock

(1.6662%)

since

2025/07/31

18.

Kennedy Capital Management Inc

(1.5207%)

since

2025/06/30

19.

Connor Clark & Lunn Inv Mgmt Ltd

(1.5153%)

since

2025/06/30

20.

JPMorgan Chase & Co

(1.2923%)

since

2025/06/30

21.

Kennedy Micro Cap

(1.1874%)

since

2025/06/30

22.

Palogic Value Management LP

(1.0375%)

since

2025/06/30

23.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0354%)

since

2025/07/31

24.

Fidelity Small Cap Index

(0.9609%)

since

2025/06/30

25.

Coeli Circulus Am Micro & Sm Cp I FdrSek

(0.9285%)

since

2025/08/31

26.

Nomura ACI AdvMed Impact Inv MF

(0.8634%)

since

2024/12/19

27.

Charles Schwab Investment Management Inc

(0.8506%)

since

2025/06/30

28.

iShares Russell 2000 Value ETF

(0.8335%)

since

2025/08/31

29.

Northern Trust Corp

(0.7488%)

since

2025/06/30

30.

DFA US Targeted Value I

(0.7287%)

since

2025/07/31

31.

Martin & Co Inc

(0.7235%)

since

2025/06/30

32.

Kennedy Extended Small Cap

(0.6866%)

since

2024/12/31

33.

Schroder Investment Management Group

(0.666%)

since

2025/06/30

34.

AMH Equity Ltd

(0.607%)

since

2025/06/30

35.

Dimensional US Targeted Value ETF

(0.5879%)

since

2025/08/29

36.

Fidelity Extended Market Index

(0.5422%)

since

2025/07/31

37.

Schroder Global Healthcare A Acc

(0.504%)

since

2025/07/31

38.

Schwab US Small-Cap ETF™

(0.465%)

since

2025/08/30

39.

Vanguard Russell 2000 ETF

(0.4606%)

since

2025/07/31

40.

Coeli Circulus Micro & Sm Cp I Fdr Sek

(0.4464%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.06

EPS Estimate

0.0629

EPS Difference

-0.0029

Surprise Percent

-4.6105%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.